QA: MIRA Pharmaceuticals INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001904286_2024_MIRA_Pharmaceuticals_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001904286, MIRA Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 4,858,230
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 74,213
4 LiabilitiesCurrent 558,097
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,499,537
9 ResearchAndDevelopmentExpense 1,572,962
10 remainder_Expenses 3,909,844
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,932,443
1 Liabilities 558,097
2 Expenses 11,982,343
3 Revenues 0
4 StockholdersEquity 4,374,346
5 NetIncome -11,982,343
6 ComprehensiveNetIncome -11,982,343
7 BaseVar 8,736,442
8 EconomicCapitalRatiobeforeLimitedLiability -0.891
9 EconomicCapitalRatio 1.32

Edgar->Model Mapping

Feature Distribution